January 29, 2020Open Access

Automated GMP compliant production of 18FAlF-NOTA-octreotide

Key Points

Key points are not available for this paper at this time.

Abstract

BACKGROUND: F]AlF-NOTA-octreotide were assessed in healthy rats using μPET/MR. RESULTS: F]AlF-NOTA-octreotide showed high in vivo stability and favorable pharmacokinetics with high and specific accumulation in SSTR2-expressing organs in rats. CONCLUSION: F]AlF-NOTA-octreotide in rats, with high and specific accumulation in SSTR2 expressing organs, supports clinical translation.

Demander à l'IA

Bookmark

View Full Paper

Cite This Study

Tshibangu et al. (Wed,) studied this question.

synapsesocial.com/papers/6a01379a6018b8d0892decc3 https://doi.org/https://doi.org/10.1186/s41181-019-0084-1

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Solid phase extraction—an alternative to the use of rotary evaporators for solvent removal in the rapid formulation of PET radiopharmaceuticals1999 · 90 citations
2How is 68Ga Labeling of Macrocyclic Chelators Influenced by Metal Ion Contaminants in 68Ge/68Ga Generator Eluates?2012 · 72 citations
3In vivo binding of [68Ga]-DOTATOC to somatostatin receptors in neuroendocrine tumours — impact of peptide mass2010 · 139 citations
4Functional Imaging of Neuroendocrine Tumors2011 · 12 citations
5A Novel Method of 18F Radiolabeling for PET2009 · 408 citations

Demander à l'IA

Bookmark

View Full Paper